Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell ...
CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...
Hologic has signed a definitive agreement to acquire Reveal Genomics, a Barcelona-based precision oncology company developing ...
Can a Cancer Genome Preserve Evidence of the Environmental Exposure That Helped Shape It? / Adam Butler, Anastassia Spiridou, ...
Hologic has agreed to acquire Reveal Genomics, adding the HER2DX assay to its breast cancer genomic testing portfolio, the ...
A new few-shot learning framework called scCAPReSE detects large-scale genomic rearrangements in single-cell Hi-C data using ...
A prospective trial found constitutional pathogenic variants in about 10 percent of solid tumor patients screened through ...
OPTIMA shows Prosigna assay can help many ER-positive, HER2-negative breast cancer patients safely avoid chemotherapy.
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a new strategy to make cancer-fighting ...
Two studies involving investigators at Cedars-Sinai Guerin Children’s and the University of Cambridge, U.K., highlight the ...
New Prostate Cancer Approval Reinforces the Importance of Comprehensive Genomic Testing / cancer, FDA, genomic testing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results